From Idea to Income — The Six Steps of IP Commercialisation

For many years, I have watched inventors, founders, researchers, and small innovation teams make the same painful mistakes again and again. Some rush too early. Some overprotect too soon. Some pitch for money before they can explain how the project will actually make money. Some obsess over product features while ignoring the business model that must carry the project into the market. That repeated pattern is exactly why I built and refined the six-step framework

I set out in Billion Dollar Napkin and across my later work on intellectual property commercialisation. I did not build it as a neat academic model to look good on a whiteboard. I built it because too many promising innovations were dying in the gap between invention and income.

The six steps are not random milestones. They reflect the real progression I have seen across decades of projects: (1) Ideation and Commercial Modelling, (2) Ownership and Protection, (3) Funding, (4) Transitioning, (5) Project Scaling, and (6) the Exit or Value Realisation Point. Each step has its own logic, its own risks, and its own discipline.

Miss one, or tackle them in the wrong order, and even a strong project can start bleeding cash, momentum, and confidence. Get them right, and the commercialisation pathway becomes clearer, faster, and far more investable. That does not make the process easy, but it does make it navigable. I have always believed that inventors do not need a vague motivation. They need a practical process they can own, understand, and use.

Why Great Ideas Still Fail: One of the hardest truths in innovation is that a good idea is not rare enough to guarantee success. The world is full of good ideas. Some are clever. Some are genuinely brilliant. Some solve real problems in ways that make you wonder why no one built them sooner. Yet many of them never generate meaningful income. That is not because markets are unfair, even though they sometimes are. It is because commercialisation asks different questions from invention. An inventor asks, “Can this be built?”

A commercial mind asks, “Who needs this badly enough to pay? How do they buy? what will it cost to deliver? and what path gets this to cash flow with the least waste?” That second set of questions is where many projects start wobbling.

I have seen inventors spend years refining technology without validating the market. I have seen teams push toward patents before they really understood demand. I have seen founders chase money with no credible value realisation point for the investor. I have also seen technically average projects outperform exceptional ones because the average project had a sharper commercial model, better sequencing, clearer ownership, and a path to revenue that others could understand. That is why I keep saying the same thing in different ways: the invention matters, but it is never enough on its own. Commercialisation is not the boring business layer you slap on top later. It is the structure that determines whether the idea can survive outside your own enthusiasm.

Why the Commercial Model Comes Before the Product Hype: If there is one lesson I would hammer into every inventor’s desk, it is this: the money is not in the product, it is in the commercial model wrapped around the product. I have said it in workshops, in books, in coaching sessions, and in countless project reviews because it remains the point most often missed. Inventors naturally fall in love with novelty, design, technical elegance, and the emotional satisfaction of making something new. Investors, partners, and buyers may admire those things for a few minutes, but they do not make decisions there. They make decisions around markets, margins, leverage, timing, risk, and the route to value. A dazzling invention with no believable commercial model is like a race car engine sitting on a crate in a garage. It may be powerful, but it is not winning any races by itself.

That is why my process starts with modelling. Before inventors run off toward manufacturing, fundraising, licensing, franchising, or international expansion, I want them to face the corridor of doors and deliberately close most of them. Not because options are bad, but because unfiltered options are expensive. A commercial model identifies who has the problem, how they solve it now, what they would pay to solve it better, what channel gets to them fastest, and what path gets the project to early traction without burning the team out. When that is clear, the rest of the process becomes far more coherent. When it is not, founders tend to confuse motion with progress and spend money proving things they never needed to prove first.

Step 1 — Ideation and Commercial Modelling

The first step in my framework is Ideation and Commercial Modelling, and I place it first for a reason. Most inventors assume the journey begins with the invention itself, but commercially, that is not quite right. The journey begins when the inventor becomes willing to interrogate the invention without sentiment. This is where we ask the harder questions. Who has the problem? Who decides to pay for the solution? What does that problem cost them in time, money, risk, or frustration? How are they solving it today? If my solution disappeared tomorrow, what would they do instead? How price-sensitive is the market? How many channels are available, and which of those channels can produce early cash flow without swallowing the whole company? Those are commercial questions, and they need to be asked before the project starts galloping toward expensive commitments.

When I run a commercial modelling workshop, I do not treat it like a vague brainstorm. I treat it like strategic excavation. In my work, which often begins with a large set of structured questions, the aim is not simply to encourage the founder. It is to uncover what really sits beneath the project. History matters. Demand profile matters. Pricing matters. Current stage matters. Ownership matters. External risks matter. Funding requirements matter. Exit logic matters. Resource allocation matters. Once those issues are mapped properly, the project stops being a bundle of guesses and starts becoming a sequence. That is powerful, because the biggest waste in early-stage innovation is not usually effort. It is an effort pointed in the wrong direction.

Start with Demand, Not Enthusiasm: Every good commercial model starts with demand. Not praise. Not curiosity. Not a room full of people saying, “That’s a great idea.” Demand means a definable group of buyers has a real enough problem that they will change behaviour, spend money, or commit attention to solve it. I always want to understand the user’s pain first. Who is carrying the cost of the problem? Is it the end user, the purchaser, the operator, the distributor, the maintenance team, or someone higher up the chain?

That distinction matters because commercialisation gets far easier when you know exactly where the friction sits. A founder who says, “This is for everyone,” usually has not done enough work. A founder who says, “This is for mid-sized operators in this industry who currently waste this amount every quarter on this exact issue,” is beginning to sound commercial.

This is also where I encourage inventors to separate genuine demand from vanity signals. Family support is nice, but it is not market-proof. Even early customer compliments can be deceptive if they are not attached to buying intent. I would rather know what the problem costs a user right now, what alternatives they already pay for, and how they would evaluate a switch. That tells me much more than applause.

The market is not a cheering section. It is a voting machine with wallets, procurement rules, competitive habits, and ingrained routines. If you can understand that behaviour clearly, the rest of the commercial model becomes much more precise.

Build the Commercial Model Before You Build the Dream: A lot of inventors move too quickly from concept excitement into large ambitions. They want international reach, multiple market segments, several product versions, a licensing strategy, a manufacturing strategy, and maybe a service layer on top as well. That ambition is understandable, but it can be fatal if it arrives before commercial sequencing.

In my framework, the model has to come before the dream gets too expensive. I want the founder to know which door opens first. Which route gets to cash first. Which segment can be served with the least risk. Which channel offers a fast enough path to traction that the later ambitions can be funded from results rather than hope.

I often compare this to standing in a corridor with many doors and realising that success depends not on trying them all, but on closing most of them early. That does not mean those options vanish forever. It means they are staged. A sensible project might start with one region, one buyer type, one application, and one commercial mechanism, then expand once early cash flow proves the model. This is not small thinking. It is disciplined thinking. Too many projects die from trying to carry their whole future on day one. A good commercial model lets the project breathe, prove itself, and grow in sequence.

Step 2 — Ownership and Protection

The second step is Ownership and Protection, and this is where a surprising amount of avoidable damage happens. Some inventors are far too casual at this stage. They talk openly, collaborate informally, share technical details without paper trails, and assume goodwill will protect them. It will not. Other inventors go in the opposite direction and rush straight toward patents before they have even validated enough demand to justify the clock they are starting.

That can be just as dangerous.

My view has always been that protection should be purposeful, sequenced, and linked to the commercial pathway. It is not there to soothe anxiety. It is there to reinforce value.

Ownership must be crystal clear. If developers, contractors, collaborators, or early advisers contribute to the project, I want that documented properly. If ideas arise in discussions, I want the ownership chain understood. If the project has already been shown to outsiders, I want to know what paper exists. Non-disclosure agreements, waivers of rights, contractor clauses, and other structured agreements can be extremely useful here.

They are not glamorous, but they keep the project from turning into a foggy argument later, right when a buyer, investor, or partner wants certainty. The more commercially serious the opportunity becomes, the less tolerance there is for ambiguity.

Clarify Ownership Before Momentum Creates Confusion: I have watched more than one project become messy simply because ownership questions were ignored in the exciting early stages. At the beginning, everyone feels cooperative. Then the project gains traction, outside interest grows, money appears, and suddenly old assumptions become contested positions.

That is why I insist that founders get ahead of this. Clarify who owns the IP. Clarify what contribution leads to what entitlement. Clarify whether work-for-hire arrangements actually assign rights cleanly. Clarify whether any prior employers, former partners, or service providers might try to claim part of the story. This is not legal fussiness. It is commercial hygiene.

A project with confused ownership loses speed at exactly the wrong moment. Investors hesitate because they do not want hidden disputes. Buyers hesitate because they do not want to acquire trouble. Partners hesitate because they do not want to help build value on shifting sand. Clear ownership, by contrast, creates confidence. It tells the market that the asset is real, controlled, and able to be transacted with.

Protect the Project Without Rushing Blindly: I have also long warned inventors about the danger of rushing to patent without enough commercial clarity. That warning is not anti-patent. Far from it. Protection can be vital. But timing matters. If you file too early, without validating market need, supply feasibility, or pricing logic, you may simply be starting an expensive countdown while the project is still commercially unformed.

I have seen inventors burn money this way, then scramble into capital raising just to service the next protection milestone. That puts the project in a weak position because the urgency is now driven by paperwork rather than market strength.

Protection should support the business model, not replace it. I would always rather see a founder think clearly about demand, ownership, route to market, and value before overcommitting to formal protection spend. In many cases, sensible agreements and controlled disclosure can protect the project adequately while the commercial model is still being shaped. Once the path is sharper, the founder can make more intelligent decisions about where and how to invest in stronger formal protection.

Step 3 — Funding

The third step is Funding, but this is where many inventors lose their way because they assume money is just money. It is not. The right capital can accelerate a project. The wrong capital can distort it, delay it, dilute it badly, or create obligations that trap the founder. When I talk about funding, I do not simply mean “find someone with money.” I mean find the kind of capital that fits the stage of the project, the commercial model, the timeline, the risk profile, and the likely value realisation point. The best funding conversations are never just about cash. They are about structure, leverage, incentives, control, and timing.

That is why I have spent so much time teaching inventors that a pitch is not a beauty contest for the invention. Strategic investors are not mainly listening for dazzling claims and wild return projections. They want to understand how the project makes money, how the risks are managed, who the team is, what leverage the opportunity gives them, and how they get their value back.

Many founders are shocked when they learn that ROI is often not the top driver for the right investor at the cornerstone level. But it makes sense. A sophisticated investor expects a return. What captures attention is what else the project can do for them. Can it improve their market position? Can it give them access to additional customers? Can it create a channel advantage? Can it reduce their risk because they already sit inside the relevant market? That is what changes the conversation.

The Right Capital Matters More Than Fast Capital: When founders get impatient, they often start offering poor deals to the wrong people. They think speed is the only thing that matters. That is how projects end up over-diluted, badly structured, or controlled by parties who do not actually understand the path ahead. I am much more interested in fit than speed. A funding partner who understands the market, appreciates the risks, and can see a value realisation pathway is worth far more than a casual investor who simply likes the founder’s energy.

That is why I often point inventors toward strategic or cornerstone investors who sit closer to the relevant industry. They are more likely to understand the risk properly and more likely to see leverage that an outside party would miss.

This is also why I am careful around equity. Equity is not loose change. It is future control and future value. If you give it away too early, too cheaply, or too casually, you can damage the project before it has had a chance to prove itself. I have written directly about this because I have seen inventors offer enormous slices of their company to service providers or technical contributors under weakly documented arrangements, only to discover later that they have created a power problem rather than a progress solution. Cash is scarce in early-stage projects, yes, but that does not make equity a harmless substitute. It has to be staged, documented, and linked to actual milestones.

Why Strategic Leverage Often Beats Pure ROI: One of the most useful corrections I can give an inventor is this: stop pitching only the return and start pitching the leverage. When I researched what drove strategic investors at the cornerstone level, it became clear that leverage often outranked ROI. That means the investor is asking, “What advantage does this project give me beyond the money I might make on the investment itself?”

If they are already active in the industry, perhaps the product helps them cross-sell, reduce costs, increase quote values, attract new distributors, or lock in customers more tightly. If they can see those secondary gains clearly, the investment becomes much easier to justify.

This is powerful because it also reduces perceived risk. A strategically aligned investor is not staring at the project from the outside with only spreadsheets and hope. They may already have channels, customers, or market experience that make the project more commercially obvious to them.

In some cases, they may even be able to structure their role as a collaborative research partner, which can open different economic advantages as the project develops. The deeper point is simple: good funding is not just about sourcing capital. It is about building a structure where the investor has a reason to help the project win.

Step 4 — Transitioning

The fourth step is Transitioning, and in many ways, this is the step that separates projects that stay trapped in R&D from projects that actually reach the market. I have always said that the skills required to research and develop a product are radically different from the skills required to commercialise it. That sounds obvious, but it is astonishing how often teams ignore it.

A technically capable development team can spend years perfecting, refining, improving, and iterating a product, while never really crossing over into commercial activity. They remain in a comfort zone of development because that is where they feel competent and in control. The market, unfortunately, does not reward endless refinement. It rewards useful things delivered through functioning commercial systems.

This is why I place so much emphasis on the transition from concept to project. At this stage, proof of concept has to be real. The commercial pathway has to be visible. The handover from R&D thinking to commercial thinking must be treated seriously. In Billion Dollar Napkin, I talk about the trade sale audit as a formal mechanism that forces this handover mindset.

Whether the people change completely or partially, the point remains the same: commercial responsibility must become distinct from technical development. If everything stays bundled inside the R&D mindset, the project usually starts cycling back into more development every time the market presents friction. That becomes a loop, and loops kill momentum.

Moving From R&D to Commercialisation: Transitioning means the project begins to behave differently. It starts caring about channels, margins, field trials, customer response, approvals, packaging, sales logic, and the shape of early revenue. It stops behaving like an experiment and starts behaving like an offer. I always want the founder to understand that this is a change in posture as much as a change in activity. The project is no longer asking, “Can we improve it?” as its central question. It is now asking, “Can we sell it profitably, repeatedly, and with enough structure that someone bigger would later want to back, buy, or scale it?”

This is also the stage where many founders need to let go of the fantasy that they must personally control everything. In fact, one of the major reasons projects stall is because the innovator cannot separate technical ownership from commercial management. That does not mean the founder becomes irrelevant. Quite the opposite. It means the founder’s strengths must be deployed in the right place while the project assembles the commercial capability needed for growth. When that handover is done well, the project becomes investable in a completely different way.

Step 5 — Project Scaling

The fifth step is Project Scaling, and this is where commercial discipline becomes even more important. A project can survive early-stage ambiguity because founders can compensate with personal energy, manual work, and heroic improvisation.

Scaling strips a lot of that cover away. Once demand grows, the project needs systems, repeatability, supply confidence, margin discipline, distribution logic, and a realistic understanding of how quickly the business can expand without breaking itself. I have seen projects that were perfectly healthy at a small level collapse when they tried to jump too far too fast. Scaling is not just more. It is more without chaos.

The other trap here is premature breadth. Founders become tempted by every adjacent opportunity once the first signs of traction appear. New geographies, new product versions, new channels, new strategic partnerships, new licensing offers. Some of those are good opportunities. Some are glitter. The only sensible way to scale is to expand from proven footholds.

I have always encouraged inventors to get one segment cash-flow positive before asking it to fund the rest of the empire. Cash matters. Timing matters. Sequence matters. If the project does not respect those things, growth can become the thing that kills it.

Scale With Focus, Systems, and Market Proof: A scalable project has to know what is already working. Which customer type buys fastest? Which channel has the lowest friction? Which version of the offer creates the healthiest margin? Which operational bottleneck appears first when demand rises? These questions matter because scaling amplifies both strengths and flaws. If the commercial model is sharp, growth creates leverage.

If the commercial model is fuzzy, growth magnifies waste. I have always preferred steady, evidence-backed expansion over theatrical growth plans built on optimistic spreadsheets. Markets do not reward ambition on its own. They reward consistency, reliability, and value delivered at increasing volume without destroying the economics.

This is also where collaboration, distribution, licensing, and partnerships can become powerful if they fit the model. I have written about collaborative research partnerships precisely because they can accelerate quality, compress timelines, and unlock channels that a founder could not reach alone. Half of a much larger and faster-moving result can be commercially smarter than total ownership of a slower, more fragile pathway. Scaling forces founders to think like that. It forces them to weigh control against speed, economics against emotion, and structure against ego.

Step 6 — The Exit or Value Realisation Point

The sixth step is the Exit, although I often prefer the term Value Realisation Point because it describes the intention more accurately. I do not teach this step as a compulsory escape hatch. There is no obligation for any party to exit just because a project reaches a point of value. What matters is that the option exists. That option is essential because investors, partners, and even founders need to know where and how value can become tangible.

 If a project never defines that point, it is asking participants to step into a tunnel with no visible opening at the far end. Most serious capital will not do that.

A value realisation point might take the form of a trade sale, a licensing deal, a strategic acquisition, a listing pathway, a buy-back structure, or an equity event that turns paper value into something usable. The important thing is clarity. What is the mechanism? Who is the likely buyer or acquirer? What triggers the opportunity? What level of traction or market proof makes it plausible? What terms preserve optionality for those who wish to stay involved?

I have always wanted founders to understand that this step is not about becoming desperate to sell. It is about building enough commercial value that selling, licensing, scaling further, or partially realising value all become live options rather than fantasies.

That distinction matters enormously. When the project is built only to be sold, it often feels brittle and performative. When the project is built to be commercially strong enough that a sale becomes one attractive option among several, it becomes much more powerful. Buyers respect that. Investors respect that.

Most importantly, the founder negotiates from strength rather than urgency. That is why I use the term value realisation point. It captures both the flexibility and the commercial maturity that the project should be working toward.

Conclusion

If I had to compress decades of commercialisation work into one core message, it would be this: ideas do not become income because they are exciting. They become income because they move through the right sequence with enough discipline, realism, and commercial structure to survive the market. That is exactly why I frame the process around six steps: Ideation and Commercial Modelling, Ownership and Protection, Funding, Transitioning, Project Scaling, and the Exit or Value Realisation Point. Each step matters because each step answers a different commercial question. Together, they create a pathway that takes an idea from possibility to value.

The common thread running through all six is clarity. Clarity about demand. Clarity about ownership. Clarity about what kind of funding fits. Clarity about when the project must stop behaving like R&D and start behaving like a business. Clarity about how growth will be managed. Clarity about where value becomes real. Without that clarity, inventors tend to burn time proving the wrong things, talking to the wrong people, and chasing the wrong opportunities.

With that clarity, even a modest project can become surprisingly powerful. In the end, commercialisation is not about stripping the soul from innovation. It is about giving innovation a structure strong enough to carry its own weight in the real world.